Literature DB >> 3789431

Effects of thiopental, fentanyl, and etomidate on upper extremity somatosensory evoked potentials in humans.

R W McPherson, B Sell, R J Traystman.   

Abstract

The effects of three anesthetic induction agents on somatosensory evoked potentials (SEP) were assessed in unpremedicated patients who were without neurologic abnormality of the upper extremities. SEP was assessed by stimulation of the nondominant median nerve and responses were recorded over Erbs point (N10), second cervical vertebra (N14), and the contralateral cortex (P15, N20, P23 latencies, and P15-N20 and N20-P23 amplitudes). Nine patients received thipental (4 mg/kg, iv bolus), nine patients received fentanyl (25 micrograms/kg, iv bolus), and nine patients received etomidate (0.4 mg/kg, iv bolus). SEP was assessed before and after drug administration at motor threshold stimulus intensity. Thiopental increased the latency of N10, N14, and N20. The amplitudes of N10-, N14-, and scalp-recorded waves were not altered by thiopental. Fentanyl increased N20 and P23 latency and decreased the amplitude of P15-N20. Etomidate increased latency of N20 and P23 without alteration of latencies of N10 or N14 and increased the amplitude of P15-N20 and N20-P23, while the amplitude of N10 was unchanged and the amplitude of N14 was decreased. It is concluded that thiopental or fentanyl causes only modest alterations in early waves of upper extremity SEP, whereas etomidate increases the amplitude of scalp-recorded waves. The effect of etomidate on SEP may make diagnosis of neurologic injury more difficult because of the changing waveform.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3789431     DOI: 10.1097/00000542-198612000-00004

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  13 in total

1.  Cortico-centric effects of general anesthetics on cerebrocortical evoked potentials.

Authors:  Logan J Voss; James W Sleigh
Journal:  Neurosci Bull       Date:  2015-12       Impact factor: 5.203

2.  Repair of the facial nerve in the cerebellopontine angle using freeze-thawed skeletal muscle autografts. An experimental surgical study in the sheep.

Authors:  M A Glasby; R E Clutton; S J Drew; M G O'Sullivan; I R Whittle
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 3.  Neurological Prognostication in Children After Cardiac Arrest.

Authors:  Alyssa E Smith; Stuart H Friess
Journal:  Pediatr Neurol       Date:  2020-03-15       Impact factor: 3.372

4.  The effect of midazolam on median nerve somatosensory evoked potentials.

Authors:  K Lauer; C Munshi; S Larson
Journal:  J Clin Monit       Date:  1994-05

5.  A prospective study of outcome predictors after severe brain injury in children.

Authors:  B G Carter; W Butt
Journal:  Intensive Care Med       Date:  2005-04-28       Impact factor: 17.440

Review 6.  [Intraoperative electrophysiological monitoring with evoked potentials].

Authors:  R Nitzschke; N Hansen-Algenstaedt; J Regelsberger; A E Goetz; M S Goepfert
Journal:  Anaesthesist       Date:  2012-04       Impact factor: 1.041

7.  Venlafaxine and oxycodone have different effects on spinal and supraspinal activity in man: a somatosensory evoked potential study.

Authors:  Dina Lelic; Massimiliano Valeriani; Iben W D Fischer; Albert Dahan; Asbjørn M Drewes
Journal:  Br J Clin Pharmacol       Date:  2017-01-16       Impact factor: 4.335

8.  Monitoring of somatosensory evoked potentials during carotid endarterectomy.

Authors:  A Amantini; M Bartelli; G de Scisciolo; M Lombardi; M Macucci; R Rossi; C Pratesi; F Pinto
Journal:  J Neurol       Date:  1992-05       Impact factor: 4.849

9.  Visual evoked potentials during etomidate administration in humans.

Authors:  O Z Chi; J Subramoni; D Jasaitis
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

Review 10.  Electroencephalography and analgesics.

Authors:  Lasse Paludan Malver; Anne Brokjaer; Camilla Staahl; Carina Graversen; Trine Andresen; Asbjørn Mohr Drewes
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.